Literature DB >> 6827984

Sitosterol and cholesterol metabolism in a patient with coexisting phytosterolemia and cholestanolemia.

H J Lin, C Wang, G Salen, K C Lam, T K Chan.   

Abstract

Sitosterol and cholesterol metabolism were studied in a patient with coexisting phytosterolemia and cholestanolemia, and in a control subject, both on similar diets containing about 170 mg cholesterol and 135 mg phytosterols per day. The turnover of 22,23-3H-sitosterol and 4-14C-cholesterol, given intravenously, were followed for up to 372 days. The specific activity-time curves for both sterols were resolved into two exponentials and fitted into a two-pool model. The half-lives of both exponential curves for sitosterol, in the patient, were abnormally long. Equilibration of the tracer between the two pools, in the patient, occurred at about 30 days as compared to 10-15 days in the control subject. The daily turnover of sitosterol in the patient was estimated to be 10 times greater than that in the control subject. The patient's total body exchangeable pool of sitosterol was 9.6 g or about 80 times the amount found in the control. The patient's plasma phytosterol levels fell by 25% when he went on a diet containing only 10 mg phytosterols per day. During this period the specific activity of his plasma sitosterol with respect to an equilibrated dose of 3H-labeled tracer remained constant; this was compatible with the absence of endogenous synthesis. Cholesterol turnover in the patient showed prolonged half-lives for both exponential curves and reduced fractional daily loss from the fast-exchanging pool. The patient's xanthoma sterols underwent 16% and 55% exchange with plasma sitosterol and cholesterol, respectively, on day 60, indicating the presence of a third exchangeable pool.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827984     DOI: 10.1016/0026-0495(83)90216-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.

Authors:  L B Nguyen; S Shefer; G Salen; G C Ness; G S Tint; F G Zaki; I Rani
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

2.  ABCG5/G8 deficiency in mice reduces dietary triacylglycerol and cholesterol transport into the lymph.

Authors:  Linda S Zhang; Min Xu; Qing Yang; Danwen Lou; Philip N Howles; Patrick Tso
Journal:  Lipids       Date:  2015-02-13       Impact factor: 1.880

3.  Phytosterolaemia in three unrelated South African families.

Authors:  G M Berger; W M Deppe; A D Marais; M Biggs
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

4.  Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia.

Authors:  T H Beaty; P O Kwiterovich; M J Khoury; S White; P S Bachorik; H H Smith; B Teng; A Sniderman
Journal:  Am J Hum Genet       Date:  1986-04       Impact factor: 11.025

5.  Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis.

Authors:  R E Gregg; W E Connor; D S Lin; H B Brewer
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

Review 6.  Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5ABCG8.

Authors:  Kori Williams; Allison Segard; Gregory A Graf
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.